Shujun Yang

机构：Lanzhou University Second Hospital, Henan Provincial People's Hospital, Lanzhou University · ORCID：0000-0002-1572-5747

发表论文 41 篇 · 总被引 559 次 · h-index 13

代表论文

• A genetic predictive model for precision treatment of diffuse large B-cell lymphoma with early progression (2020 · Biomarker Research · 被引 33)
• MiRNA-363-3p/DUSP10/JNK axis mediates chemoresistance by enhancing DNA damage repair in diffuse large B-cell lymphoma (2022 · Leukemia · 被引 29)
• lncRNA PART1, manipulated by transcriptional factor FOXP2, suppresses proliferation and invasion in ESCC by regulating the miR‑18a‑5p/SOX6 signaling axis (2021 · Oncology Reports · 被引 23)
• Efficacy and safety of MIL60 compared with bevacizumab in advanced or recurrent non-squamous non-small cell lung cancer: a phase 3 randomized, double-blind study (2021 · EClinicalMedicine · 被引 14)
• Protective properties of extracellular vesicles in sepsis models: a systematic review and meta-analysis of preclinical studies (2023 · Journal of Translational Medicine · 被引 13)
• The mitochondrial fusion-associated protein MFN2 can be used as a novel prognostic molecule for clear cell renal cell carcinoma (2023 · BMC Cancer · 被引 8)